1. As to the Plaintiff KRW 500,000,000 and its KRW 200,000 among them, the Defendant shall pay to the Plaintiff KRW 300,000,000 from March 22, 2010.

1. Basic facts

A. The Defendant is the representative director of C Co., Ltd (hereinafter “C”) for the purpose of manufacturing and selling medical devices.

B. On March 19, 2010, the Defendant: (a) the Plaintiff’s office located in Yeongdeungpo-gu Seoul Metropolitan Government D operated the Plaintiff Company; (b) the agent’s sales revenue cannot be included in the sales revenue of the Plaintiff; (c) the agent’s sales revenue cannot be included in the sales revenue of the Plaintiff; and (d) the Crycll was supplied as another company; (b) the 10th unit of the products was supplied with the 10th unit of the products; and (c) there was no development of flexible auxiliary material; (c) the employees’ wages were not paid due to C’s insolvency; and (d) it was impossible to list the products with C’s sales revenue and profit-making demand for cancellation of the investment from the new securities; (b) as long as the investment amounting to C’s sales revenue and profit-making revenue would be considerable to KRW 600,000,0000,000,0000,0000,0000,0000,0000.

The defendant shall have the plaintiff accept KRW 200,000,000,000,000,000 from March 22, 2010.